<html>
<head>PUBMED IDs for MAP17</head>
<body bgcolor='#C5F0F2'><h1>MAP17</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10496535/'>PDZK1, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome 1q21, interacts with cMOAT (MRP2), the multidrug resistance-associated protein.</a> September 25  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10951271/'>The membrane-associated protein pKe#192/MAP17 in human keratinocytes.</a> August 22  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11156618/'>Long-range comparison of human and mouse SCL loci: localized regions of sensitivity to restriction endonucleases correspond precisely with peaks of conserved noncoding sequences.</a> January 13  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11997341/'>Transcriptional regulation of the stem cell leukemia gene (SCL)--comparative analysis of five vertebrate SCL loci.</a> May 9  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12556478/'>Targeted disruption of the PDZK1 gene by homologous recombination.</a> January 31  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12754212/'>Identification of small PDZK1-associated protein, DD96/MAP17, as a regulator of PDZK1 and plasma high density lipoprotein levels.</a> May 20  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15923636/'>Transcriptional regulation of the SCL locus: identification of an enhancer that targets the primitive erythroid lineage in vivo.</a> June 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17230460/'>Large scale genetic screen identifies MAP17 as protein bypassing TNF-induced growth arrest.</a> January 19  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17405831/'>The human reticulocyte transcriptome.</a> April 5  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17426052/'>MAP17 overexpression is a common characteristic of carcinomas.</a> April 12  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17548903/'>MAP17 enhances the malignant behavior of tumor cells through ROS increase.</a> June 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18046316/'>Interactions of the growth-related, type IIc renal sodium/phosphate cotransporter with PDZ proteins.</a> November 30  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19601982/'>MAP17 is associated with the T-helper cell cytokine-induced down-regulation of filaggrin transcription in human keratinocytes.</a> November 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/22266858/'>p38α limits the contribution of MAP17 to cancer progression in breast tumors.</a> December 14  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23418532/'>MAP17 and SGLT1 protein expression levels as prognostic markers for cervical tumor patient survival.</a> August 28  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25837675/'>MAP17 (PDZKIP1) Expression Determines Sensitivity to the Proteasomal Inhibitor Bortezomib by Preventing Cytoprotective Autophagy and NFκB Activation in Breast Cancer.</a> April 14  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27288013/'>MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2.</a> June 12  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28153862/'>The Cargo Protein MAP17 (PDZK1IP1) Regulates the Cancer Stem Cell Pool Activating the Notch Pathway by Abducting NUMB.</a> February 4  2017<br></body></html>
